维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Momary"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	High-density lipoprotein subclasses and their relationship to cardiovascular disease显示文摘	H. Robert Superko Lakshmana Pendyala Paul T. Williams Katherine M. Momary Spencer B. King Brenda C. Garrett	2012	Journal of Clinical Lipidology2012，，6：	2
2	Genetic and clinical predictors of warfarin dose requirements in African Americans显示文摘	Cavallari LH Langaee TY Momary KM	2010	Clin Pharmacol Ther2010，87，4：	1
3	Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir 显示文摘	Jann MW Spmtlin V Momary K	2012	Euro J Clin Pharmacol2012，68，5：	1
4	Antibiotic drug interactions显示文摘	Pai MP Momary KM Rodvold KA	2006	Med Clin North Am2006，90，6：	1
5	Statins personalized显示文摘	SUPERKO HR MOMARY KM LI Y	2012	Med Clin North Am2012，96，1：	1
6	Statins personalized显示文摘	Superko HR Momary KM Li Y	2012	Med Clin North Am2012，96，1：	1
7	Genetic causes of clopi- dogrel nonresponsiveness: which ones really count? 显示文摘	Momary KM Dorsch MP Bates ER	2010	Phar- macotherapy2010，30，3：	1
8	Ge- netic and clinical predictors of warfarin dose require- ments in African Americans 显示文摘	Cavallari LH Langaee TY Momary KM	2010	Clin Pharmacol T- her2010，87，4：	1
9	Factors asso- ciated with clopidogrelnonresponsiveness显示文摘	Kathryn M Momary Michael P Dorsch	2010	Future Cardiol2010，6，2：	1
10	Genetic and clinical predictors of warfarin dose requirements in African Americans 显示文摘	Cavallari LH Lmgaee TY Momary KM	2010	Clin Pharmacol Ther2010，87，4：	1
11	Factors associated with clopidogrel nonre- sponsiveness显示文摘	Momary KM Dorsch MP	2010	Future Cardiol2010，6，2：	1
12	A reliable algorithm of homotopy analysis method for solving nonlinear fraction- al differential equations显示文摘	ODIBAT Z MOMARI S XU H	2010	Applied Mathematical Model- ling2010，34，3：	1
13	Modified homotopy perturba- tion method: application to quadratic riccati differential equation of fractional order显示文摘	ODIBAT Z MOMARI S	2008	Chaos Solitons & Frac- tals2008，36，1：	1
14	Pharma- cogenomics of warfarin dose requirements in hispanics显示文摘	CAVALLARI L H MOMARY K M PATEL S R	2011	Blood Ceils Mole and Dis2011，46，8：	1
15	Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement显示文摘	Wang D Chen H Momary KM	2008	Blood2008，112，4：	1
16	Ge- netic and clinical predictors of warfarin dose requirements in Afri-can Americans 显示文摘	CAVALLARI LH LANGAEE TY MOMARY KM	2010	Clin Pharmacol Ther2010，87，4：	1
17	Structure activity relationships of a synthetic penta peptide that specifically releases growth hormone in vitro 显示文摘	Bowers C Y Momary F Reyndds G A	1980	Endocrinology1980，106，：	1
18	Genetic causes of clopi- dogrel nonresponsiveness : which ones really count 显示文摘	Momary KM Dorsch MP Bates ER	2010	Phar- macotherapy2010，30，3：	1
19	Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended -release/indinavir显示文摘	Jann MW Spratlin V Momary K	2012	Eur J Clin Pharmacol2012，68，5：	1
20	Genetic and clinical predictors of warfarin dose requirements in African Americans显示文摘	Cavallari LH Langaee TY Momary KM	2010	Clinical pharmacology & Therapeutics2010，87，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示